无线连续双光传输用于编程的PDT in vivo.
Jiayi Liu1, Bowen Sun2, Wenkai Li3
1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Light, science & applications
|May 14, 2024
概括
这项研究介绍了一种用于光动力学治疗 (PDT) 的智能纳米载体系统. 该系统通过光降解载体和顺序光敏剂激活来增强癌症治疗,提高了安全性和有效性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 光动力疗法 (PDT) 在治疗深层癌症方面面临挑战,原因是光敏剂的输送和光透率差.
- 光敏剂在纳米载体内自我灭和有限的活性氧物种 (ROS) 扩散降低了PDT的有效性.
- 要克服这些局限性,需要一个智能纳米载体系统来进行光触发的降解和光敏剂激活.
研究的目的:
- 开发一种光敏感的聚合物纳米载体系统,用于增强光动力疗法 (PDT).
- 研究一种无线,可植入的微LED设备,用于连续发射光,以控制纳米载体释放和光敏剂激活.
- 使用数字模拟优化PDT参数,以提高肝癌模型的有效性和安全性.
主要方法:
- 合成一个光敏聚合物纳米载体,封装一个光敏化剂 (RB-M).
- 开发一种可植入的无线双波长微LED装置,用于连续光照射.
- 基于代理的数字模拟以确定最佳照射时间,剂量和光敏剂度.
- 在实验室和体内验证在一个 ортотоп性大鼠肝肝细胞癌模型.
主要成果:
- 开发的纳米载体系统在暴露于光线时成功降解,释放光敏剂.
- 连续的低剂量光照射策略提高了PDT的疗效.
- 减少了光敏剂和辐射剂量,导致治疗成功.
- 在大鼠肝癌模型中的验证证实了该策略的有效性和安全性.
结论:
- 对光敏感的纳米载体和顺序照射策略代表了PDT对深层癌症的重大进步.
- 这种方法通过减少光敏剂和光剂量来提高治疗安全性.
- 开发的系统显示了改善癌症治疗结果的临床翻译的希望.
更多相关视频
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.5K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.0K
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
